Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Allogeneic Stem Cell Transplantation with Immunodepleted Grafts for Lymphoproliferative Malignancies

Nicolas Novitzky, MD PhD, Valda Thomas, Dipl, MDech

Blood (2014) 124 (21): 1252.

https://doi.org/10.1182/blood.V124.21.1252.1252

Published: 2014

Journal Articles

Is There a Role for Autologous Stem Cell Transplantation (Auto SCT) for Patients with Acute Myelogenous Leukaemia? A Retrospective Analysis.

Nicolas Novitzky, MD, PhD, Valda Thomas, Dipl, MedTech, Cecile du Toit, MBChB, MMed, Andrew McDonald, MBChB, FCP(SA)

Blood (2010) 116 (21): 1689.

https://doi.org/10.1182/blood.V116.21.1689.1689

Published: 2010

Journal Articles

In Patients with Aplastic Anaemia, Conditioning with Reduced Intensity Followed by Infusion of T-Cell Depleted Grafts Is Associated with Limited Transplant Related Morbidity and Universal Survival.

Nicolas Novitzky, MD, PhD, Valda Thomas, Dip Med Tech, Cecile E. Du Toit, MBChB, MMed, Andrew B. McDonald, MBChB, FCP

Blood (2007) 110 (11): 3289.

https://doi.org/10.1182/blood.V110.11.3289.3289

Published: 2007

Journal Articles

Myeloablative Conditioning Followed by T-Cell Depletion Is Associated with Low Treatment Related Mortality.

Nicolas Novitzky, MD, PhD, Valda Thomas, N.D., Med Tech, Cecile du Toit, MBChB, M.Med, Andrew McDonald, MBChB, FCP

Blood (2006) 108 (11): 5221.

https://doi.org/10.1182/blood.V108.11.5221.5221

Published: 2006

Journal Articles

In Multiple Myeloma (MM) CAMPATH-1 Antibodies “In the Bag” Reduce the Early Toxicity of Stem Cell Transplantation from Graft vs. Host Disease (GvHD) and Seem To Be Associated with Improved Long Term Outcome.

Nicolas Novitzky, MD, PhD, Valda Thomas, N.D., Med Tech, Cecile du Toit, MBChB,M.Med.

Blood (2006) 108 (11): 5360.

https://doi.org/10.1182/blood.V108.11.5360.5360

Published: 2006

Journal Articles

Allogeneic Stem Cell Transplantation for Lymphoid Malignancies.

Nicolas Novitzky, MD, PhD, Valda Thomas, Cecile Du Toit, Andrew McDonald

Blood (2005) 106 (11): 5418.

https://doi.org/10.1182/blood.V106.11.5418.5418

Published: 2005

Journal Articles

Myeloablative Conditioning Is Well Tolerated by Older Patients Receiving T-Cell Depleted Grafts.

Nicolas Novitzky, MD, PhD, Valda Thomas, Geoff Hale, Herman Waldmann

Blood (2005) 106 (11): 5266.

https://doi.org/10.1182/blood.V106.11.5266.5266

Published: 2005

Journal Articles

Radiotherapy-Based Conditioning Is Effective Immunosuppression for Patients Undergoing Transplantation with T-Cell Depleted Stem Cell Grafts for Severe Aplasia.

Nicolas Novitzky, MD, PhD, Valda Thomas, Helen Stubbings, Geoff Hale, Herman Waldmann

Blood (2004) 104 (11): 1819.

https://doi.org/10.1182/blood.V104.11.1819.1819

Published: 2004

NARROW

Allogeneic Stem Cell Transplantation with Immunodepleted Grafts for Lymphoproliferative Malignancies

Is There a Role for Autologous Stem Cell Transplantation (Auto SCT) for Patients with Acute Myelogenous Leukaemia? A Retrospective Analysis.

In Patients with Aplastic Anaemia, Conditioning with Reduced Intensity Followed by Infusion of T-Cell Depleted Grafts Is Associated with Limited Transplant Related Morbidity and Universal Survival.

Myeloablative Conditioning Followed by T-Cell Depletion Is Associated with Low Treatment Related Mortality.

In Multiple Myeloma (MM) CAMPATH-1 Antibodies “In the Bag” Reduce the Early Toxicity of Stem Cell Transplantation from Graft vs. Host Disease (GvHD) and Seem To Be Associated with Improved Long Term Outcome.

Allogeneic Stem Cell Transplantation for Lymphoid Malignancies.

Myeloablative Conditioning Is Well Tolerated by Older Patients Receiving T-Cell Depleted Grafts.

Radiotherapy-Based Conditioning Is Effective Immunosuppression for Patients Undergoing Transplantation with T-Cell Depleted Stem Cell Grafts for Severe Aplasia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only